<scp>FOLFIRINOX</scp> or gemcitabine/nab‐paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision‐making in real‐world-Reference-Cited by-同舟云学术

FOLFIRINOX or gemcitabine/nab‐paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision‐making in real‐world

Published:2022-09-22 Issue:3 Volume:152 Page:458-469
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Marschner Norbert¹^ORCID,Hegewisch‐Becker Susanna²,Reiser Marcel³,von der Heyde Eyck⁴,Bertram Mathias⁵,Hollerbach Stephan H.⁶,Kreher Stephan⁷,Wolf Thomas⁸,Binninger Adrian⁹,Chiabudini Marco¹⁰,Kaiser‐Osterhues Anja¹¹,Jänicke Martina⁹,

Affiliation:

1. Praxis für Interdisziplinäre Onkologie & Hämatologie Freiburg Germany

2. Hämatologisch‐Onkologische Praxis Eppendorf (HOPE) Hamburg Germany

3. PIOH—Praxis Internistische Onkologie und Hämatologie Köln Germany

4. Onkologische Schwerpunktpraxis Hannover Germany

5. Hämatologisch Onkologischer Schwerpunkt Dres. Müller‐Hagen/Bertram/Graefe/Kollegen Hamburg Germany

6. Allgemeines Krankenhaus Celle Klinik für Gastroenterologie Celle Germany

7. Hämatologisch‐Onkologische Schwerpunktpraxis Bad Liebenwerda Bad Liebenwerda Germany

8. BAG, Gemeinschaftspraxis Hämatologie‐Onkologie Dresden Germany

9. Clinical Epidemiology and Health Economics, iOMEDICO Freiburg Germany

10. Biostatistics iOMEDICO Freiburg Germany

11. Medical Department iOMEDICO Freiburg Germany

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.34271

Reference46 articles.

1. Pancreatic cancer

2. Robert Koch‐Institut.Gesellschaft der Epidemiologischen Krebsregister in Deutschland e.V. Krebs in Deutschland 2017/2018. Häufigkeiten und Trends [Internet]. 13. Ausgabe. Berlin: Robert Koch‐Institut.https://www.krebsdaten.de/Krebs/DE/Content/Publikationen/Krebs_in_Deutschland/krebs_in_deutschland_node.html. Accessed December 2 2021.

3. Cancer statistics, 2020

4. National Cancer Institute.SEER Cancer Statistics Review 1975‐2018 [Internet];2021.https://seer.cancer.gov/csr/1975_2018/sections.html. Accessed December 2 2021.

5. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Head‐to‐head comparison of treatment sequences in advanced pancreatic cancer—Real‐world data from the prospective German TPK clinical cohort study;International Journal of Cancer;2024-07-02

2. Cancer cell membrane-coated upconversion nanoparticles/ZnxMn1-xS core-shell nanoparticles for targeted photodynamic and chemodynamic therapy of pancreatic cancer;Materials Today Bio;2023-10

3. Clinical Impact of Nutrition and Inflammation Assessment Tools in Pancreatic Cancer Treatment;Anticancer Research;2023-08-30

4. Serum Amyloid a Predicts Prognosis and Chemotherapy Efficacy in Patients with Advanced Pancreatic Cancer;Journal of Inflammation Research;2023-03